Christopher Heery, CHIEF MEDICAL OFFICER at Arcellx, Inc. (ACLX), sold 92,630 shares at $69.59 ($6.5M) on 2024-03-22, disclosed to the SEC on 2024-03-26.
Scheduled sale ($6.5M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.59 | 10,057 | $700K | 10.8% |
| 2 | $69.59 | 10,057 | $700K | 10.8% |
| 3 | $70.13 | 25,975 | $1.8M | 28.1% |
| 4 | $70.13 | 25,975 | $1.8M | 28.1% |
| 5 | $71.36 | 4,333 | $309K | 4.8% |
| 6 | $71.36 | 4,333 |
| $309K |
| 4.8% |
| 7 | $72.25 | 1,000 | $72K | 1.1% |
| 8 | $68.55 | 2,555 | $175K | 2.7% |
| 9 | $68.55 | 2,555 | $175K | 2.7% |
| 10 | $69.36 | 2,034 | $141K | 2.2% |
| 11 | $69.36 | 2,034 | $141K | 2.2% |
| 12 | $70.19 | 861 | $60K | 0.9% |
| 13 | $70.19 | 861 | $60K | 0.9% |
| Total | $70.03 avg | 92,630 | $6.5M | 100% |
| Filing → |
| ACLX | SELL | 2026-01-12 | $393K | — | Filing → |
| ACLX | SELL | 2025-11-17 | $31K | — | Filing → |
| ACLX | SELL | 2025-09-30 | $2.9M | — | Filing → |